Xander van Wijk
Xander is a board-certified clinical chemist and Senior Director of Medical and Scientific Affairs at Beckman Coulter Diagnostics. He has extensive experience in clinical chemistry, mass spectrometry, blood gas testing, toxicology, and molecular diagnostic testing. At the University of California San Francisco, he investigated emerging clinical toxicology cases through collaboration with the California Poison Control System and discovered that the adverse effects and deaths caused by counterfeit drugs were due to high quantities of fentanyl. These published findings were broadly covered in the media, fulfilling Xander’s desire to produce impactful work.